Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant chemotherapy with or without bevacizumab after complete resection of NSCLC
2007-003195-19Phase 3Completed
- Sponsor
- Cancer Trials Ireland
- Start
- Jun 2007
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of bevacizumab in non-small cell lung cancer (NSCLC) (2 arms), sponsored by Cancer Trials Ireland. Primary endpoint: Overall survival. Started Jun 2007; status: completed.
02
Drugs
bevacizumab
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2007-003195-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003195-19.